Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and immunogenicity of a recombinant tetravalent dengue vaccine in 9-16 year olds: a randomized, controlled, phase II trial in Latin America.
Villar LÁ, Rivera-Medina DM, Arredondo-García JL, Boaz M, Starr-Spires L, Thakur M, Zambrano B, Miranda MC, Rivas E, Dayan GH. Villar LÁ, et al. Among authors: zambrano b. Pediatr Infect Dis J. 2013 Oct;32(10):1102-9. doi: 10.1097/INF.0b013e31829b8022. Pediatr Infect Dis J. 2013. PMID: 24067553 Clinical Trial.
Economic impact of dengue illness in the Americas.
Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH. Shepard DS, et al. Among authors: zambrano b. Am J Trop Med Hyg. 2011 Feb;84(2):200-7. doi: 10.4269/ajtmh.2011.10-0503. Am J Trop Med Hyg. 2011. PMID: 21292885 Free PMC article.
Immunogenicity and safety of an investigational hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-hepatitis B-Haemophilus influenzae B conjugate combined vaccine in healthy 2-, 4-, and 6-month-old Argentinean infants.
Tregnaghi MW, Zambrano B, Santos-Lima E. Tregnaghi MW, et al. Among authors: zambrano b. Pediatr Infect Dis J. 2011 Jun;30(6):e88-96. doi: 10.1097/INF.0b013e318212eb80. Pediatr Infect Dis J. 2011. PMID: 21372751 Clinical Trial.
Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPV//PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV//PRP-T booster vaccination at 18 months of age in healthy Argentinean infants.
Tregnaghi M, Zambrano B, Santos-Lima E. Tregnaghi M, et al. Among authors: zambrano b. Pediatr Infect Dis J. 2012 Jan;31(1):e24-30. doi: 10.1097/INF.0b013e318242460a. Pediatr Infect Dis J. 2012. PMID: 22157567
Safety and immunogenicity of an investigational fully liquid hexavalent DTaP-IPV-Hep B-PRP-T vaccine at two, four and six months of age compared with licensed vaccines in Latin America.
Macías M, Lanata CF, Zambrano B, Gil AI, Amemiya I, Mispireta M, Ecker L, Santos-Lima E. Macías M, et al. Among authors: zambrano b. Pediatr Infect Dis J. 2012 Aug;31(8):e126-32. doi: 10.1097/INF.0b013e318258400d. Pediatr Infect Dis J. 2012. PMID: 22531237 Clinical Trial.
The history of dengue outbreaks in the Americas.
Brathwaite Dick O, San Martín JL, Montoya RH, del Diego J, Zambrano B, Dayan GH. Brathwaite Dick O, et al. Among authors: zambrano b. Am J Trop Med Hyg. 2012 Oct;87(4):584-93. doi: 10.4269/ajtmh.2012.11-0770. Am J Trop Med Hyg. 2012. PMID: 23042846 Free PMC article.
75 results